Director Charlie E. Cheever III filed a Form 4 with the SEC on November 19, 2026, disclosing two open-market purchases of CV Sciences, Inc. common stock on November 17 and November 18, 2026.

Key Highlights

  • First purchase: Cheever acquired 1,628,093 shares of common stock on November 17, 2026, at a price of $0.01 per share.
  • Second purchase: Cheever acquired 402,618 shares of common stock on November 18, 2026, also at a price of $0.01 per share.
  • Combined shares acquired: The two transactions total 2,030,711 shares purchased across the two days.
  • Resulting ownership: Following the November 18 transaction, Cheever directly beneficially owned 34,120,348 shares of common stock, according to the filing.
  • Relationship to issuer: Cheever is identified in the filing as a Director of CV Sciences, Inc.
  • Transaction codes: Both transactions are coded "P," indicating open-market purchases, per the filing.

Cheever's Two-Day Purchase of CV Sciences Common Stock

According to the Form 4 filed with the SEC, Charlie E. Cheever III, a director of CV Sciences, Inc. (OTC:CVSI), reported two separate purchases of the company's common stock. On November 17, 2026, Cheever acquired 1,628,093 shares at $0.01 per share, bringing his directly held beneficial ownership to 33,717,730 shares following that transaction, as disclosed in the filing.

The following day, November 18, 2026, Cheever made a second purchase of 402,618 shares, again at a price of $0.01 per share. After this transaction, his directly held beneficial ownership stood at 34,120,348 shares of common stock, according to the filing. Both transactions carry a "P" transaction code, indicating open-market purchases under the SEC's coding instructions.

The form was signed by Marc Simeone and filed on November 19, 2026. The filing contains no entries in Table II, meaning no derivative securities were reported as acquired, disposed of, or beneficially owned in connection with these transactions. No Rule 10b5-1 plan checkbox was indicated as applicable to either purchase.

What Was Disclosed

CV Sciences director Charlie E. Cheever III reported two open-market purchases of common stock on November 17 and November 18, 2026, totaling 2,030,711 shares at $0.01 per share, resulting in direct beneficial ownership of 34,120,348 shares.